Development agreements require legal possession or effective enjoyment for capital gains transfer; permissive possession and deferred consideration de...
Prolonged sterilisation of development rights supports capital-gains treatment, while business-income disallowances cannot govern capital-gains comput...
Additional evidence in transfer pricing dispute leads to fresh examination, while tax deductions, TDS credit, fee and refund interest require verifica...
Category II AIF pass-through taxation preserves non-business income character; investment receipts cannot be reclassified without applying recognised ...
The ITAT directed the AO to treat the excess consideration paid in slump sale transactions as goodwill and allow depreciation accordingly, following a coordinate bench's precedent. The tribunal allowed the set-off of brought forward unabsorbed depreciation, distinguishing it from business loss. Transfer Pricing adjustments on AMP expenses were disallowed due to lack of evidence of association or statutory basis for the Bright Line Test. The tribunal directed inclusion of Satyatej Commercial Co. Ltd. as a comparable for import of finished goods transactions, excluding freight costs. It also ordered exclusion of Hand Innovations Inc. and RG Medical Diagnostics for benchmarking indenting commission transactions based on product and territorial similarity. The tribunal held that reimbursement of expenses could not be valued at nil without independent comparable evidence and disallowed the TPO's and DRP's treatment, allowing the related appeal ground. All contested grounds raised by the assessee were allowed accordingly.
The ITAT directed the AO to treat the excess consideration paid in slump sale transactions as goodwill and allow depreciation accordingly, following a coordinate bench's precedent. The tribunal allowed the set-off of brought forward unabsorbed depreciation, distinguishing it from business loss. Transfer Pricing adjustments on AMP expenses were disallowed due to lack of evidence of association or statutory basis for the Bright Line Test. The tribunal directed inclusion of Satyatej Commercial Co. Ltd. as a comparable for import of finished goods transactions, excluding freight costs. It also ordered exclusion of Hand Innovations Inc. and RG Medical Diagnostics for benchmarking indenting commission transactions based on product and territorial similarity. The tribunal held that reimbursement of expenses could not be valued at nil without independent comparable evidence and disallowed the TPO's and DRP's treatment, allowing the related appeal ground. All contested grounds raised by the assessee were allowed accordingly.
Note: It is a system-generated summary and is for quick reference only.